Literature DB >> 27183452

Coronary flow reserve as a link between exercise capacity, cardiac systolic and diastolic function.

Juuso I Blomster1, Sara Svedlund2, Helena U Westergren3, Li-Ming Gan4.   

Abstract

BACKGROUND: Decreased coronary flow reserve (CFR) is associated with increased risk of adverse cardiovascular events. We sought to investigate how CFR from left anterior descending (LAD) coronary artery reflects clinical markers of cardiac function.
METHODS: We enrolled 400 patients referred for myocardium perfusion scintigraphy due to chest pain at Sahlgrenska University Hospital in Gothenburg, Sweden. Transthoracic echocardiography including adenosine-assisted CFR in LAD was performed at a separate occasion.
RESULTS: Median age was 62years (range 32-83) and 47% were female. Prior myocardial infarction had occurred in 28% of the population. In adjusted multivariate models, CFR in LAD was associated with echocardiography left ventricle ejection fraction at rest (β=0.97, p=0.033) as well as under stress (β=1.52, p=0.0056) and maximum exercise capacity (β=6.27, p=0.026). CFR in LAD outweighed left ventricle ejection fraction as the determinant of maximum exercise capacity. Hyperaemic diastolic mitral annulus peak velocity measured by vector velocity imaging was inversely associated with LAD CFR (β=-0.39, p=0.0077). In subgroup analyses these findings were associated with normal coronary perfusion in myocardium perfusion scintigraphy.
CONCLUSIONS: In patients with angina-like symptoms CFR measured in LAD reflects well both systolic and diastolic cardiac function emphasizing the essential role of myocardial microvascular circulation in cardiac physiology.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Cardiac imaging; Coronary flow reserve; Diastolic function; Echocardiography; Systolic function

Mesh:

Year:  2016        PMID: 27183452     DOI: 10.1016/j.ijcard.2016.04.179

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1.  Microvascular Disease, Peripheral Artery Disease, and Amputation.

Authors:  Joshua A Beckman; Meredith S Duncan; Scott M Damrauer; Quinn S Wells; Joey V Barnett; David H Wasserman; Roger J Bedimo; Adeel A Butt; Vincent C Marconi; Jason J Sico; Hilary A Tindle; Marc P Bonaca; Aaron W Aday; Matthew S Freiberg
Journal:  Circulation       Date:  2019-07-08       Impact factor: 29.690

2.  Inhibition of prolyl hydroxylases alters cell metabolism and reverses pre-existing diastolic dysfunction in mice.

Authors:  Xiaochen He; Heng Zeng; Richard J Roman; Jian-Xiong Chen
Journal:  Int J Cardiol       Date:  2018-08-24       Impact factor: 4.164

3.  Reduced Coronary Flow Reserve Is Associated with Impaired Ventricular-vascular Interaction in Patients with Obstructive Sleep Apnea.

Authors:  Hyemoon Chung; Sung Wan Kim; Hyung Oh Kim; Jung Myung Lee; Jong Shin Woo; Jin Bae Kim; Soo Joong Kim; Weon Kim; Kwon Sam Kim; Woo-Shik Kim
Journal:  Int J Heart Fail       Date:  2020-06-02

4.  Effects of cardiac rehabilitation with and without meditation on myocardial blood flow using quantitative positron emission tomography: A pilot study.

Authors:  Sabahat Bokhari; Robert H Schneider; John W Salerno; Maxwell V Rainforth; Carolyn Gaylord-King; Sanford I Nidich
Journal:  J Nucl Cardiol       Date:  2019-09-16       Impact factor: 3.872

5.  Association Between Elevated Pulse Pressure and High Resting Coronary Blood Flow Velocity in Patients With Angiographically Normal Epicardial Coronary Arteries.

Authors:  Maria Lembo; Rosa Sicari; Roberta Esposito; Fausto Rigo; Lauro Cortigiani; Francesco Lo Iudice; Eugenio Picano; Bruno Trimarco; Maurizio Galderisi
Journal:  J Am Heart Assoc       Date:  2017-06-29       Impact factor: 5.501

6.  Exercise Combined with Rhodiola sacra Supplementation Improves Exercise Capacity and Ameliorates Exhaustive Exercise-Induced Muscle Damage through Enhancement of Mitochondrial Quality Control.

Authors:  Yaoshan Dun; Suixin Liu; Wenliang Zhang; Murong Xie; Ling Qiu
Journal:  Oxid Med Cell Longev       Date:  2017-11-22       Impact factor: 6.543

7.  Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial.

Authors:  Vesa Anttila; Antti Saraste; Juhani Knuuti; Pekka Jaakkola; Marja Hedman; Sara Svedlund; Maria Lagerström-Fermér; Magnus Kjaer; Anders Jeppsson; Li-Ming Gan
Journal:  Mol Ther Methods Clin Dev       Date:  2020-06-01       Impact factor: 6.698

8.  Patients with moderate chronic kidney disease without heart disease have reduced coronary flow velocity reserve.

Authors:  Pavlos Kashioulis; Cecilia Wallentin Guron; Maria K Svensson; Ola Hammarsten; Aso Saeed; Gregor Guron
Journal:  ESC Heart Fail       Date:  2020-07-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.